---
$id: https://graph.org.ai/products/commodity/51144115
$type: Product
source: UNSPSC
code: "51144115"
title: "Dextroamphetamine"
class: "51144100"
classTitle: "Stimulant or anorexiant amphetamines"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dextroamphetamine

**UNSPSC Code**: 51144115
**Class**: [Stimulant or anorexiant amphetamines](Stimulant or anorexiant amphetamines.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cns stimulant with the molecular formula C9H13N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TZ47U051FI, chemically known as phenethylamine, alpha-methyl-, d- but more generally known as dexamfetamine, which bears US NIH Compound Identifier 5826. European Medicines Agency schedules Dexamfetamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07019MIG. The term DEXAMFETAMINE is an International Non-Proprietary Name. World Health Organization schedules dexamfetamine in its Anatomical Therapeutic Chemical (ATC) Classification. DEXAMFETAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, DEXTROAMPHETAMINE remains US FDA's Preferred Term for this commodity. Dextroamphetamine bears US NLM identifiers UMLS ID C0011812 and NCI Concept Code C28981. SMILES: NC(CC1CCCCC1)C.

